Showing results (51-60 of 630) with videos related to
Sort By:
Pageof 63
Thrombosis and Haemostasis|April 30, 1976
Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivoU Hedner, I M Nilsson, S E BergentzActa Chirurgica Scandinavica|January 1, 1989
Influence of aprotinin, a protease inhibitor, on porcine E. coli shock. Studies on coagulation, fibrinolytic and hemodynamic responseE Svartholm, U Haglund, J Ljungberg, et al.Acta Chirurgica Scandinavica. Supplementum|January 1, 1988
Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacementT Mätzsch, D Bergqvist, H Fredin, et al.Scandinavian Journal of Plastic and Reconstructive Surgery|January 1, 1976
Fibrinolytic activity in wound secretionsM Aberg, U Hedner, S Jacobsson, et al.Thrombosis Research|July 15, 1992
Recombinant human factor VIIa (rFVIIa) in a rabbit stasis modelV Diness, C Bregengaard, E Erhardtsen, et al.Thrombosis Research|April 27, 2001
Anti- and procoagulant activities in factor VII-deficient subjectsJ Astermark, L Tengborn, U Hedner, et al.Thrombosis Research|November 15, 1983
Anticoagulant effects of two types of low molecular weight heparin administered subcutaneouslyD Bergqvist, U Hedner, E Sjörin, et al.Thrombosis Research|December 15, 1982
Demonstration of 99mTc-labelled plasmin on the surface of ex vivo thrombiL Tengborn, U Hedner, M Rohlin, et al.Thrombosis and Haemostasis|February 3, 1987
Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteersT Mätzsch, D Bergqvist, U Hedner, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
Clinical experience with recombinant factor VIIaJ Lusher, J Ingerslev, H Roberts, et al.Pageof 63